SugenTech Accelerates Development of 'COVID-19' Antigen Rapid Diagnostic Kit Applying Next-Generation Analytical Technology

[Asia Economy Reporter Yoo Hyun-seok] SuzenTech announced on the 22nd that it has obtained a patent for the high-sensitivity analysis technology essential for developing a novel coronavirus (COVID-19) antigen diagnostic kit, the 'time-resolved fluorescence signal analysis device.'

The 'time-resolved fluorescence signal analysis technology' that SuzenTech has successfully patented this time is an advanced technology compared to existing fluorescence signal analysis techniques. It is a 'high-sensitivity fluorescence analysis technology' that can reduce analysis errors caused by noise such as excitation light, background light, and autofluorescence, which are drawbacks of existing technologies. Because it has fewer errors caused by noise, it is highly accurate in measuring 'ultra-trace' biomarkers and is regarded as next-generation fluorescence analysis technology.

SuzenTech plans to first apply the newly developed time-resolved fluorescence signal analysis technology to the analyzer device for the COVID-19 antigen rapid diagnostic kit currently under development and release it.

The time-resolved fluorescence signal analyzer developed by SuzenTech is a compact portable device that can be powered by a battery, offering excellent mobility and the ability to achieve molecular diagnostic (PCR) level accuracy. Therefore, it has the advantage of quickly confirming COVID-19 infection status at medical sites without the need for separate molecular diagnostic (PCR) equipment or infrastructure such as testing centers.

A SuzenTech official stated, "By successfully developing the time-resolved fluorescence signal analysis technology, we can apply diversified analysis platforms tailored to various diseases and biomarker characteristics to develop diagnostic kits. We will release the COVID-19 antigen rapid diagnostic kit together with the newly developed time-resolved fluorescence signal analyzer to enable rapid and accurate diagnosis of COVID-19 at medical sites such as small and medium-sized hospitals and public medical institutions."

SuzenTech plans to prepare for the prolonged COVID-19 situation by developing, following the currently exported ▲COVID-19 antibody rapid diagnostic kit, ▲COVID-19 antigen rapid diagnostic kit and analyzer, ▲antibody quantitative diagnostic kit, and ▲neutralizing antibody measurement kit to check immunity.

This content was produced with the assistance of AI translation services.